131 related articles for article (PubMed ID: 37120067)
1. Application of an AI image analysis and classification approach to characterise dissolution and precipitation events in the flow through apparatus.
Taseva AR; Persoons T; D'Arcy DM
Eur J Pharm Biopharm; 2023 Aug; 189():36-47. PubMed ID: 37120067
[TBL] [Abstract][Full Text] [Related]
2. Analytical technologies for real-time drug dissolution and precipitation testing on a small scale.
Kuentz M
J Pharm Pharmacol; 2015 Feb; 67(2):143-59. PubMed ID: 24834963
[TBL] [Abstract][Full Text] [Related]
3. In-line derivative spectroscopy as a promising application to a small-scale in vitro transfer model in biorelevant supersaturation and precipitation testing.
Jede C; Wagner C; Kubas H; Weber C; Weitschies W
J Pharm Pharmacol; 2018 Oct; 70(10):1315-1323. PubMed ID: 30062721
[TBL] [Abstract][Full Text] [Related]
4. Development and characterization of a scalable controlled precipitation process to enhance the dissolution of poorly water-soluble drugs.
Rogers TL; Gillespie IB; Hitt JE; Fransen KL; Crowl CA; Tucker CJ; Kupperblatt GB; Becker JN; Wilson DL; Todd C; Broomall CF; Evans JC; Elder EJ
Pharm Res; 2004 Nov; 21(11):2048-57. PubMed ID: 15587927
[TBL] [Abstract][Full Text] [Related]
5. In vitro dissolution models for the prediction of in vivo performance of an oral mesoporous silica formulation.
McCarthy CA; Faisal W; O'Shea JP; Murphy C; Ahern RJ; Ryan KB; Griffin BT; Crean AM
J Control Release; 2017 Mar; 250():86-95. PubMed ID: 28132935
[TBL] [Abstract][Full Text] [Related]
6. Biorelevant dissolution testing of a weak base: Interlaboratory reproducibility and investigation of parameters controlling in vitro precipitation.
Berben P; Ashworth L; Beato S; Bevernage J; Bruel JL; Butler J; Dressman J; Schäfer K; Hutchins P; Klumpp L; Mann J; Nicolai J; Ojala K; Patel S; Powell S; Rosenblatt K; Tomaszewska I; Williams J; Augustijns P
Eur J Pharm Biopharm; 2019 Jul; 140():141-148. PubMed ID: 31051249
[TBL] [Abstract][Full Text] [Related]
7. New Approach for the Application of USP Apparatus 3 in Dissolution Tests: Case Studies of Three Antihypertensive Immediate-Release Tablets.
Espíndola B; Bortolon FF; Pinto JMO; Pezzini BR; Stulzer HK
AAPS PharmSciTech; 2018 Oct; 19(7):2866-2874. PubMed ID: 29934804
[TBL] [Abstract][Full Text] [Related]
8. In vitro dissolution methodology, mini-Gastrointestinal Simulator (mGIS), predicts better in vivo dissolution of a weak base drug, dasatinib.
Tsume Y; Takeuchi S; Matsui K; Amidon GE; Amidon GL
Eur J Pharm Sci; 2015 Aug; 76():203-12. PubMed ID: 25978875
[TBL] [Abstract][Full Text] [Related]
9. The science of USP 1 and 2 dissolution: present challenges and future relevance.
Gray V; Kelly G; Xia M; Butler C; Thomas S; Mayock S
Pharm Res; 2009 Jun; 26(6):1289-302. PubMed ID: 19165579
[TBL] [Abstract][Full Text] [Related]
10. In Silico Modeling Approach for the Evaluation of Gastrointestinal Dissolution, Supersaturation, and Precipitation of Posaconazole.
Hens B; Pathak SM; Mitra A; Patel N; Liu B; Patel S; Jamei M; Brouwers J; Augustijns P; Turner DB
Mol Pharm; 2017 Dec; 14(12):4321-4333. PubMed ID: 28817288
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic Approach to Understanding the Influence of USP Apparatus I and II on Dissolution Kinetics of Tablets with Different Operating Release Mechanisms.
Lu Z; Fassihi R
AAPS PharmSciTech; 2017 Feb; 18(2):462-472. PubMed ID: 27106916
[TBL] [Abstract][Full Text] [Related]
12. Hierarchical Mass Transfer Analysis of Drug Particle Dissolution, Highlighting the Hydrodynamics, pH, Particle Size, and Buffer Effects for the Dissolution of Ionizable and Nonionizable Drugs in a Compendial Dissolution Vessel.
Salehi N; Al-Gousous J; Mudie DM; Amidon GL; Ziff RM; Amidon GE
Mol Pharm; 2020 Oct; 17(10):3870-3884. PubMed ID: 32886520
[TBL] [Abstract][Full Text] [Related]
13. Investigating the effect of solubility and density gradients on local hydrodynamics and drug dissolution in the USP 4 dissolution apparatus.
D'Arcy DM; Liu B; Corrigan OI
Int J Pharm; 2011 Oct; 419(1-2):175-85. PubMed ID: 21843609
[TBL] [Abstract][Full Text] [Related]
14. Dissolution testing of modified release products with biorelevant media: An OrBiTo ring study using the USP apparatus III and IV.
Reppas C; Vrettos NN; Dressman J; Andreas CJ; Miyaji Y; Brown J; Etherson K; Hanley S; Karkossa F; Karlsson E; Klein S; Maier GM; McAllister M; Mistry N; Rosenblatt K; Schäfer KJ; Smith KL; Tomaszewska I; Williams J; Winge F; Vertzoni M
Eur J Pharm Biopharm; 2020 Nov; 156():40-49. PubMed ID: 32882421
[TBL] [Abstract][Full Text] [Related]
15. Using USP I and USP IV for discriminating dissolution rates of nano- and microparticle-loaded pharmaceutical strip-films.
Sievens-Figueroa L; Pandya N; Bhakay A; Keyvan G; Michniak-Kohn B; Bilgili E; Davé RN
AAPS PharmSciTech; 2012 Dec; 13(4):1473-82. PubMed ID: 23090112
[TBL] [Abstract][Full Text] [Related]
16. First-Principles and Empirical Approaches to Predicting In Vitro Dissolution for Pharmaceutical Formulation and Process Development and for Product Release Testing.
Zaborenko N; Shi Z; Corredor CC; Smith-Goettler BM; Zhang L; Hermans A; Neu CM; Alam MA; Cohen MJ; Lu X; Xiong L; Zacour BM
AAPS J; 2019 Feb; 21(3):32. PubMed ID: 30790200
[TBL] [Abstract][Full Text] [Related]
17. Regulating the pH of bicarbonate solutions without purging gases: Application to dissolution testing of enteric coated tablets, pellets and microparticles.
Scott N; Patel K; Sithole T; Xenofontos K; Mohylyuk V; Liu F
Int J Pharm; 2020 Jul; 585():119562. PubMed ID: 32565282
[TBL] [Abstract][Full Text] [Related]
18. Exploring bulk volume, particle size and particle motion definitions to increase the predictive ability of in vitro dissolution simulations.
Navas-Bachiller M; Persoons T; D'Arcy DM
Eur J Pharm Sci; 2022 Jul; 174():106185. PubMed ID: 35398291
[TBL] [Abstract][Full Text] [Related]
19. Hydrodynamic and species transfer simulations in the USP 4 dissolution apparatus: considerations for dissolution in a low velocity pulsing flow.
D'Arcy DM; Liu B; Bradley G; Healy AM; Corrigan OI
Pharm Res; 2010 Feb; 27(2):246-58. PubMed ID: 20012167
[TBL] [Abstract][Full Text] [Related]
20. In Vitro, in Silico, and in Vivo Assessments of Intestinal Precipitation and Its Impact on Bioavailability of a BCS Class 2 Basic Compound.
Kou D; Zhang C; Yiu H; Ng T; Lubach JW; Janson M; Mao C; Durk M; Chinn L; Winter H; Wigman L; Yehl P
Mol Pharm; 2018 Apr; 15(4):1607-1617. PubMed ID: 29522347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
